| 49408-8 |
Herpes virus 8 DNA |
NCnc |
Bone mar |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49408-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HHV8 DNA # Mar NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV8; HHV-8; Human herpes virus; ID; Infectious Disease; InfectiousDisease; Kaposi's Sarcoma-Associated Herpesvirus; KSHV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49409-6 |
Herpes virus 8 DNA |
NCnc |
BAL |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49409-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HHV8 DNA # BAL NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV8; HHV-8; Human herpes virus; ID; Infectious Disease; InfectiousDisease; Kaposi's Sarcoma-Associated Herpesvirus; KSHV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 4941-1 |
HLA-DQ5(1) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DQ5(1) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4941-1 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DQ5(1) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; i; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49410-4 |
JC virus DNA |
NCnc |
CSF |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49410-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # CSF NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.73 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49411-2 |
JC virus DNA |
NCnc |
Urine |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49411-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # Ur NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load |
2.73 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49412-0 |
JC virus DNA |
NCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49412-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # Spec NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.73 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49413-8 |
JC virus DNA |
NCnc |
Ser/Plas |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49413-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # SerPl NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.73 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49414-6 |
JC virus DNA |
NCnc |
Bld |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49414-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # Bld NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49415-3 |
JC virus DNA |
NCnc |
Bone mar |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49415-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # Mar NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49416-1 |
JC virus DNA |
NCnc |
BAL |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49416-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # BAL NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49417-9 |
JC virus DNA |
NCnc |
Tiss |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49417-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
JCPyV DNA # Tiss NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49418-7 |
Papova virus SV40 DNA |
NCnc |
BAL |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49418-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # BAL NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Simian virus 40; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49419-5 |
Papova virus SV40 DNA |
NCnc |
Tiss |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49419-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Tiss NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Strand Displacement Amplification; SV-40; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 4942-9 |
HLA-DQ6(1) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DQ6(1) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4942-9 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DQ6(1) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; i; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49420-3 |
Papova virus SV40 DNA |
NCnc |
Bone mar |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49420-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Mar NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49421-1 |
Papova virus SV40 DNA |
NCnc |
CSF |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49421-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # CSF NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49422-9 |
Papova virus SV40 DNA |
NCnc |
Bld |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49422-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Bld NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49423-7 |
Papova virus SV40 DNA |
NCnc |
Urine |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49423-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Ur NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; UA; UR; Urn; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49424-5 |
Papova virus SV40 DNA |
NCnc |
Ser/Plas |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49424-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # SerPl NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; Simian virus 40; SR; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49425-2 |
Papova virus SV40 DNA |
NCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49425-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Spec NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Spec; Strand Displacement Amplification; SV-40; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49426-0 |
Papova virus SV40 DNA |
NCnc |
Stool |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49426-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
SV40 DNA # Stl NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bowel movement; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Simian virus 40; Stl; Stool = Fecal; Strand Displacement Amplification; SV-40; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49427-8 |
Parvovirus B19 DNA |
NCnc |
Amnio fld |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49427-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B19V DNA # Amn NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; B19 virus; B19V; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49428-6 |
Parvovirus B19 DNA |
NCnc |
BAL |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49428-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B19V DNA # BAL NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; B19 virus; B19V; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 49429-4 |
Parvovirus B19 DNA |
NCnc |
Bone mar |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
49429-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B19V DNA # Mar NAA+probe |
|
|
|
N |
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; B19 virus; B19V; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.7 |
2.22 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 4943-7 |
HLA-DQ6(1) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DQ6(1) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4943-7 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DQ6(1) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; i; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
